JMI Labs

Executive Summary

JMI Laboratories is a premier microbiology reference laboratory based in North Liberty, Iowa, specializing in supporting the development of antimicrobial therapies. Founded in 2001, the company offers comprehensive services including global antimicrobial surveillance, drug development support, molecular studies, and clinical trial services. As a critical partner for pharmaceutical companies, JMI helps navigate the complex regulatory pathway for new antibiotics and antifungals. With the growing threat of antimicrobial resistance and increased focus on developing novel antimicrobials, JMI is well-positioned to benefit from rising demand for specialized testing and surveillance services. The company's role in facilitating clinical trials and providing essential data for regulatory submissions makes it a key enabler in the infectious disease space. While JMI operates as a private entity without disclosed financials, its established track record and essential services suggest a stable and potentially growing business model.

Upcoming Catalysts (preview)

• Q2 2026New partnership with a major pharmaceutical company for antibiotic development70% success
• Q4 2026Expansion of laboratory services or geographic footprint50% success
• Q1 2027FDA approval of a client's antibiotic that relied on JMI's testing services40% success